jump to navigation

When Will the FTC Investigate the FDA? November 16, 2009

Posted by federalist in Healthcare, Regulation.

The massive healthcare lobby can’t break the FDA’s stranglehold on medical innovation.  Can a bureaucratic turf war do it?  Consider the following statement by the Federal Trade Commission Chairman, Jon Leibowitz:

We’re going to be very concerned about any practice that could increase prescription-drug costs to American consumers.  You can’t let drug safety be used as a tool to delay … competition.

Of course, the ellipses conceal the qualifier that will dash our hopes: The FTC is only interested in ensuring competition of “generics” for drugs coming off patent.  If a useful drug never makes it to the market in the first place because of the excessive regulation by the FDA he probably doesn’t care.



No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: